Medrogestone
Medrogestone is a new orally active Progestin. Medrogestone shows a marked local progestational effect. Medrogestone maintains pregnancy in ovariectomized rats. Medrogestone inhibits ovulation. Medrogestone prevents pregnancy. Medrogestone produces a significant reduction in the severity of benign prostatic hypertrophy[1][2].
Product Specifications
CAS Number
977-79-7
UNSPSC
12352211
Hazard Statement
H315-H319-H320
Target
Progesterone Receptor
Related Pathways
Vitamin D Related/Nuclear Receptor
Field of Research
Endocrinology
Smiles
CC([C@@]1(C)CC[C@@]2([H])[C@]3([H])C=C(C)C4=CC(CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O)=O
Molecular Formula
C23H32O2
Molecular Weight
340.50
Precautions
P264-P280-P302+P352-P305+P351+P338-P362
References & Citations
[1]Revesz C, et al. Biological activity of medrogestone: a new orally active progestin. J Reprod Fertil. 1966 Dec;12 (3) :473-87. |[2]Rangno RE, et al. Treatment of benign prostatic hypertrophy with medrogestone. Clin Pharmacol Ther. 1971 Jul-Aug;12 (4) :658-65.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
